首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Extractive Spectrophotometric Methods for Determination of Pramipexole Dihydrochloride in Pharmaceutical Preparations through Ion-Pair Technique
【24h】

Extractive Spectrophotometric Methods for Determination of Pramipexole Dihydrochloride in Pharmaceutical Preparations through Ion-Pair Technique

机译:离子对技术萃取光度法测定药物制剂中盐酸普拉克索

获取原文
           

摘要

Simple, sensitive, precise, reproducible and validated visible spectrophotometric methods have been developed for the determination of antiparkinson agent, pramipexole dihydrochloride monohydrate (PRM) in pure form and pharmaceutical preparations. The proposed spectrophotometric methods are based on the formation of yellow colored ion-pair complexes between PRM, and three dyes, bromocresol purple (BCP), bromophenol blue (BPB and) methyl orange (MO) with absorption maxima at 410, 416 and 421 nm, respectively. Several parameters such as pH, buffer type, reagent volume, sequence of addition and effect of extracting solvent were optimized to achieve high sensitivity, stability, low blank reading and reproducible results. Under the optimum reaction conditions, linear relationships were found between the absorbance's over the concentration ranges of 2.0–12, 1.0-10 and 2.0–16 μg ml-1 with good correlation coefficients ≥ 0.9992 and LOD of 0.58, 0.28 and 0.60 μg ml-1 and the calculated molar absorptivity values are 1.1737 × 104, 2.3043 × 104 and 1.2847 × 104 l mol-1 cm-1 using BCP, BPB and MO methods, respectively. The stoichiometric ratio of the formed ion-pair complexes was found to be 1:1 (drug: reagent) for all methods as deduced by Job's method of continuous variation. Various analytical parameters have been evaluated and the results have been validated by statistical data. The proposed methods were validated in accordance with ICH guidelines and successfully applied to the analysis of PRM in pharmaceutical preparations (tablets). Statistical comparison of the results obtained by applying the proposed methods with those of the official method revealed good agreement and proved that there was no significant difference in the accuracy and precision between the results. The reliability of the methods was further ascertained by performing recovery studies using the standard addition method.
机译:已经开发出了简单,灵敏,精确,可重现和验证的可见分光光度法,用于测定抗帕金森剂,普拉克索二水合盐酸一水合物(PRM)的纯形式和药物制剂。提议的分光光度法基于PRM与三种染料在410、416和421 nm处具有最大吸收的溴甲酚紫(BCP),溴酚蓝(BPB和)甲基橙(MO)之间形成黄色离子对络合物, 分别。优化了多个参数,例如pH,缓冲液类型,试剂量,添加顺序和萃取溶剂的效果,以实现高灵敏度,稳定性,低空白读数和可重现的结果。在最佳反应条件下,在2.0–12、1.0-10和2.0–16μgml-1的浓度范围内,吸光度之间存在线性关系,相关系数≥0.9992,LOD为0.58、0.28和0.60μgml- 1和BCP,BPB和MO方法计算得出的摩尔吸收率分别为1.1737×104、2.3043×104和1.2847×104 l mol-1 cm-1。通过乔布的连续变化法推导的所有方法,发现形成的离子对络合物的化学计量比为1:1(药物:试剂)。已评估了各种分析参数,并已通过统计数据验证了结果。所提出的方法已按照ICH指南进行了验证,并成功地应用于药物制剂(片剂)中PRM的分析。通过使用提议的方法与官方方法获得的结果的统计比较显示出很好的一致性,并证明了结果之间的准确性和精确度没有显着差异。通过使用标准添加方法进行回收率研究进一步确定了方法的可靠性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号